Chemoinformaics analysis of N-gamma-Glutamyl-S-propylcysteine
| Molecular Weight | 292.357 | nRot | 10 |
| Heavy Atom Molecular Weight | 272.197 | nRig | 3 |
| Exact Molecular Weight | 292.109 | nRing | 0 |
| Solubility: LogS | -1.61 | nHRing | 0 |
| Solubility: LogP | -2.281 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 40.8159 |
| nHD | 4 | BPOL | 25.1281 |
| QED | 0.413 |
| Synth | 3.048 |
| Natural Product Likeliness | 0.27 |
| NR-PPAR-gamma | 0.183 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.072 |
| HIA | 0.041 |
| CACO-2 | -6.308 |
| MDCK | 0.0000069 |
| BBB | 0.384 |
| PPB | 0.107068 |
| VDSS | 0.379 |
| FU | 0.768248 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.025 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.041 |
| CYP2c9-inh | 0.145 |
| CYP2c9-sub | 0.452 |
| CYP2d6-inh | 0.023 |
| CYP2d6-sub | 0.137 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.004 |
| CL | 3.536 |
| T12 | 0.839 |
| hERG | 0.012 |
| Ames | 0.015 |
| ROA | 0.008 |
| SkinSen | 0.129 |
| Carcinogencity | 0.082 |
| EI | 0.043 |
| Respiratory | 0.037 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.676511 |